Precise execution

MC Services is...

Client News

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

read more

MC Services at analytica in Munich on April 03, 2014 (FINANCE DAY)

MC Services, the international Investor Relations and Public Relations Company, hosted a booth at this year’s analytica meeting, the leading trade fair for modern laboratory technology and biotechnology. Our focus this year was on the FINANCE DAY on April 03, 2014, in which also some of our clients participated in panel sessions.

read more

MC Services one of the main sponsors of the 7th DVFA Life Science Conference 2014

This year MC Services acted as one of the main sponsors of the 7th DVFA Life Science Conference, which took place in Frankfurt on May 07, 2014. Over recent years the DVFA Life Science Conference has become a highly valued platform to discuss new innovative technologies, therapies and products with financial market participants.

The conference focused on innovative treatment strategies for cancer, an area where MC Services’ clients have taken leading roles.

read more



MorphoSys and Galapagos Advance Joint Antibody Program in Inflammatory Diseases into Preclinical Development 


MagForce Expands into the U.S. Market


Trianta announces extension of research funding in the transregional Collaborative Research Centre of the German Research Foundation (DFG) for adoptive T cell therapy 


Shareholders support Management proposals at SYGNIS’ AGM with overwhelming majority 


Medigene's Drug Veregen® Launched in Canada


Medigene secures funding for its cancer immunotherapy programmes through capital increase 


Online Werkstattportal Autobutler erhält 5,8 Mio. Euro für die Geschäftsentwicklung in Deutschland


WILEX publishes Half-yearly Financial Report 2014


WILEX AG successfully completes capital reduction


TIMELESS HOMES Markets Luxury Chalet at the Foot of the Wilder Kaiser Mountain Range 


Medigene AG confirms final subscription price for new shares and final conversion price for convertible bonds


PAION vergibt Lizenzrechte für Remimazolam an Pendopharm in Kanada


PAION AG successfully comletes placement of new shares


4SC hires experienced pharmaceutical manager and oncology expert


Reallocation of 4SC shares successfully completed, free float increased


Transgene Announces Presentation of Data on TG1050 Immunotherapy against Chronic Hepatitis B and Provides Update on its Joint Venture with Tasly Pharmaceuticals in China


Epigenomics AG Provides Update on Regulatory Status and Information on Additional Clinical Study for Epi proColon® in the U.S.